• Streptavidin-FITC for LNP Biotin Detection

  2026-09-04

  Streptavidin-FITC converts biotinylated LNP, nucleic-acid, and antibody workflows into bright, microscope- and flow-compatible readouts. This guide focuses on distinguishing particle association from functional delivery while providing practical controls for charge-, corona-, and endolysosomal studies.

• Dacarbazine Workflows for Cancer Research

  2026-09-04

  Build more reproducible Dacarbazine cytotoxicity studies with solvent-aware preparation, time-resolved readouts, and orthogonal validation. This guide connects practical assay execution with translational questions in melanoma, Hodgkin lymphoma, and sarcoma research while clarifying what supportive-care evidence can—and cannot—show.

• Anlotinib hydrochloride Assay Workflows

  2026-09-03

  Build reproducible angiogenesis assays around receptor phosphorylation, endothelial phenotypes, and ERK pathway readouts. This guide translates a clinically informative desmoplastic small round cell tumor case into practical cancer research workflows while separating literature evidence from optimization recommendations.

• In Vitro Drug Response Metrics in Cancer Research

  2026-09-02

  Hannah Schwartz’s dissertation distinguishes relative viability from fractional viability, showing that growth inhibition and cell killing are related but non-equivalent dimensions of anticancer drug response. This measurement framework helps researchers design better time-resolved experiments, interpret apoptosis assay data more carefully, and avoid treating reduced viability as definitive evidence of cell death.

• Streptavidin-FITC for Biotin Tracking Workflows

  2026-09-02

  Streptavidin-FITC converts biotinylated antibodies, nucleic acids, and nanoparticles into measurable FITC fluorescence across imaging and flow assays. Its strongest use-case is modular tracking, where the same high-affinity reagent can connect intracellular trafficking studies with immunohistochemistry, immunofluorescence, and flow cytometry.

• AGO1 Controls Protein Folding in Stem Cell Fate

  2026-09-02

  The 2024 Developmental Cell study shows that AGO1 and AGO2 have opposing roles in mouse embryonic stem cell fate: AGO1 sustains stemness, whereas AGO2 promotes differentiation through the miRNA pathway. Its central innovation is the identification of an RNA-independent AGO1–HOP interaction that supports folding of transcriptional regulators with intrinsically disordered regions.

• Berberine Hydrochloride: From AMPK to Mitochondria

  2026-09-01

  Berberine hydrochloride connects AMPK-driven metabolic regulation with lipid, apoptotic, ferroptotic, and mitochondrial readouts. This guide shows how to build a mechanistically disciplined workflow for metabolic disease research and cardiovascular disease research.

• WEHI-539: Selective BCL-XL Inhibitor Workflows

  2026-08-31

  WEHI-539 enables selective interrogation of BCL-XL-dependent survival, from mitochondrial apoptosis assays to cancer stem cell sensitization. This workflow-focused guide separates biochemical potency from cellular response and shows how to troubleshoot formulation, timing, controls, and combination experiments.

• PD0325901 for Reliable Cell Assays

  2026-08-31

  This scenario-based guide explains how PD0325901 (SKU A3013) can support mechanistic cell viability, proliferation, and cytotoxicity experiments through MEK pathway inhibition. It combines formulation guidance, assay controls, data interpretation, and evidence-linked recommendations for more defensible laboratory decisions.

• MnTBAP Chloride: A Redox Assay Strategy

  2026-08-30

  MnTBAP Chloride is a cell-permeable SOD mimetic for testing how mitochondrial superoxide connects oxidative stress with inflammation and behavior. This article develops an assay-centered framework that extends chronic-stress findings into practical study design, controls, and interpretation.

• ATP as a Translational Map of Mitochondrial Control

  2026-08-29

  Adenosine Triphosphate is more than a readout of cellular energy. This thought-leadership article connects ATP state, OGDH regulation, mitochondrial proteostasis, and purinergic receptor signaling to help translational researchers design experiments that distinguish correlation from mechanism.

• Amyloid Beta-Peptide (1-40): Assay Design

  2026-08-28

  Amyloid Beta-Peptide (1-40) (human) is a defined molecular input for resolving how amyloid assemblies alter assay signals. This guide translates ratiometric fibril imaging into practical decisions for Alzheimer’s disease research peptide workflows, with emphasis on controls, storage, and interpretation.

• Vemurafenib: Mapping Melanoma Resistance

  2026-08-28

  Vemurafenib and PLX4032 can serve as more than BRAF pathway inhibitors: they are experimentally tractable probes for separating oncogenic MAPK dependence from adaptive resistance. This thought-leadership guide connects compound mechanism, multi-omics evidence, assay strategy, and translational decision-making in melanoma research.

• SR 11302: AP-1 Blockade for Cancer Assays

  2026-08-28

  SR 11302 enables selective AP-1 pathway interrogation without activating retinoid receptors, making it useful for separating transcriptional signaling from nonspecific cytotoxicity. This guide translates its cancer-cell applications into reproducible proliferation, reporter, and macrophage-polarization workflows inspired by colitis-associated colorectal cancer research.

• Torin2 mTOR Inhibitor: Assay Workflow

  2026-08-27

  Torin2 combines potent mTOR pathway inhibition with a practical workflow for viability, migration, and apoptosis studies in cancer models. This guide shows how to connect mTOR output measurements with the latest RNA Pol II cell-death findings without overinterpreting pathway crosstalk.

8650 records 1/577 page Next 12345 下5页 Last page